Drug:
Reaction: DRUG DOSE OMISSION BY DEVICE
20260101 - 20261231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 26940099 |
US |
69 | 1 |
Drug dose omission by device, Device malfunction, |
||||
PEGFILGRASTIM, |
||||
| 2 | 26940385 |
US |
2 | |
Irritable bowel syndrome, Asthenia, Nausea, Hypotension, Bone pain, Drug dose omission by device, Device issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 3 | 26940389 |
US |
1 | |
Catheterisation cardiac, Weight increased, Injection site pain, Injection site haemorrhage, Device defective, Drug dose omission by device, Needle issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, SUVOREXANT, OXYBUTYNIN CHLORIDE, |
||||
| 4 | 26940420 |
US |
67 | 2 |
Product distribution issue, Device mechanical issue, Drug dose omission by device, |
||||
ABALOPARATIDE, |
||||
| 5 | 26940558 |
US |
66 | 2 |
Drug delivery system malfunction, Drug dose omission by device, |
||||
ABALOPARATIDE, |
||||
| 6 | 26940593 |
US |
74 | 2 |
Myalgia, Pain, Arthralgia, Device mechanical issue, Drug dose omission by device, |
||||
ABALOPARATIDE, |
||||
| 7 | 26940621 |
US |
55 | 2 |
Drug delivery system issue, Drug dose omission by device, Needle issue, Incorrect dose administered by device, |
||||
ABALOPARATIDE, |
||||
| 8 | 26940676 |
US |
66 | 2 |
Condition aggravated, Diarrhoea, Nausea, Drug dose omission by device, Device malfunction, Device mechanical issue, Device physical property issue, |
||||
ABALOPARATIDE, |
||||
| 9 | 26940863 |
US |
2 | |
Drug dose omission by device, Device deployment issue, |
||||
ABALOPARATIDE, |
||||
| 10 | 26941130 |
US |
69 | 2 |
Feeling jittery, Fungal skin infection, Dyspnoea, Heart rate increased, Fatigue, Blood calcium increased, Palpitations, Off label use, Drug dose omission by device, Liquid product physical issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 11 | 26941435 |
US |
50 | 2 |
Pericarditis, Drug dose omission by device, Device difficult to use, Therapy interrupted, |
||||
ETANERCEPT, ETANERCEPT, |
||||
| 12 | 26941442 |
2 | ||
Drug dose omission by device, Device defective, |
||||
BACLOFEN, |
||||
| 13 | 26941469 |
US |
67 | 2 |
Device defective, Needle issue, Drug dose omission by device, |
||||
ABALOPARATIDE, |
||||
| 14 | 26941517 |
US |
2 | |
Brain fog, Eye pain, Breast discomfort, Fatigue, Injection site pain, Drug dose omission by device, Device issue, |
||||
ABALOPARATIDE, |
||||
| 15 | 26941593 |
US |
68 | 2 |
Product dose omission in error, Device issue, Drug dose omission by device, Product use issue, |
||||
ABALOPARATIDE, |
||||
| 16 | 26941831 |
US |
2 | |
Device mechanical issue, Drug dose omission by device, Needle issue, |
||||
ABALOPARATIDE, CALCIUM, |
||||
| 17 | 26942567 |
US |
47 | 2 |
Liposuction, Arthralgia, Drug dose omission by device, Device difficult to use, |
||||
ETANERCEPT, ETANERCEPT, |
||||
| 18 | 26942673 |
US |
67 | |
Drug dose omission by device, Wrong technique in product usage process, Device delivery system issue, Off label use, |
||||
ALBUTEROL SULFATE, |
||||
| 19 | 26943022 |
US |
46 | |
Injection site bruising, Drug dose omission by device, Device difficult to use, |
||||
EVOLOCUMAB, |
||||
| 20 | 26943165 |
US |
59 | |
Pain, Drug dose omission by device, Device defective, Injection site discharge, |
||||
| 21 | 26943167 |
US |
||
Drug dose omission by device, Product physical consistency issue, Product leakage, Device occlusion, |
||||
OCTREOTIDE ACETATE, |
||||
| 22 | 26943219 |
US |
41 | 2 |
Seizure, Drug dose omission by device, Migraine, Drug ineffective, |
||||
GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, |
||||
| 23 | 26943321 |
US |
1 | |
Device malfunction, Drug dose omission by device, Feeling abnormal, |
||||
ORAL SEMAGLUTIDE, |
||||
| 24 | 26943540 |
US |
2 | |
Injection site pain, Device difficult to use, Drug dose omission by device, |
||||
EVOLOCUMAB, |
||||
| 25 | 26943577 |
US |
79 | |
Drug dose omission by device, Wrong technique in product usage process performed in error, Product use issue, No adverse event, |
||||
ALBUTEROL SULFATE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, AMLODIPINE, LISINOPRIL, |
||||
| 26 | 26943668 |
US |
43 | |
Drug dose omission by device, Wrong technique in product usage process performed in error, Prescription drug used without a prescription, Incorrect dose administered by device, No adverse event, |
||||
ALBUTEROL SULFATE, |
||||
| 27 | 26943877 |
EU |
13 | 2 |
Drug dose omission by device, Device information output issue, |
||||
SOMATROPIN, |
||||
| 28 | 26943882 |
US |
13 | 1 |
Drug dose omission by device, Device leakage, Device information output issue, Device physical property issue, |
||||
SOMATROPIN, |
||||
| 29 | 26943929 |
CO |
2 | |
Device breakage, Device leakage, Drug dose omission by device, |
||||
SOMATROPIN, |
||||
| 30 | 26943940 |
US |
13 | 1 |
Drug dose omission by device, Product storage issue, Device physical property issue, Device mechanical issue, |
||||
SOMATROPIN, SOMATROPIN, |
||||
| 31 | 26943962 |
US |
54 | 2 |
Carotid artery disease, Device difficult to use, Drug dose omission by device, |
||||
EVOLOCUMAB, |
||||
| 32 | 26944842 |
US |
66 | 2 |
Drug dose omission by device, Device delivery system issue, |
||||
ABALOPARATIDE, |
||||
| 33 | 26945000 |
US |
71 | 2 |
Device delivery system issue, Drug dose omission by device, |
||||
ABALOPARATIDE, |
||||
| 34 | 26945075 |
US |
2 | |
Device defective, Drug dose omission by device, Needle issue, |
||||
ABALOPARATIDE, |
||||
| 35 | 26945171 |
US |
55 | 2 |
Device defective, Drug dose omission by device, |
||||
ABALOPARATIDE, |
||||
| 36 | 26945219 |
US |
2 | |
Alopecia, Device issue, Drug dose omission by device, |
||||
ABALOPARATIDE, ABALOPARATIDE, AMLODIPINE, LOSARTAN, |
||||
| 37 | 26945282 |
US |
78 | 2 |
Device mechanical issue, Drug dose omission by device, |
||||
ABALOPARATIDE, |
||||
| 38 | 26945530 |
US |
88 | 1 |
Myocardial infarction, Wrong technique in product usage process, Drug dose omission by device, Device difficult to use, |
||||
EVOLOCUMAB, |
||||
| 39 | 26945536 |
US |
2 | |
Drug dose omission by device, Product use in unapproved indication, Device malfunction, Device delivery system issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, SPIRONOLACTONE, DESVENLAFAXINE SUCCINATE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, THYROID, PORCINE, |
||||
| 40 | 26945589 |
US |
2 | |
Wrong technique in product usage process, Drug dose omission by device, Product outer packaging issue, Device mechanical issue, Needle issue, |
||||
ABALOPARATIDE, |
||||
| 41 | 26945622 |
US |
80 | 2 |
Drug dose omission by device, Drug delivery system issue, Device issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 42 | 26945807 |
CO |
1 | |
Device information output issue, Drug dose omission by device, |
||||
SOMATROPIN, |
||||
| 43 | 26945949 |
US |
70 | 2 |
Device defective, Drug dose omission by device, Device malfunction, Needle issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, ORAL SEMAGLUTIDE, |
||||
| 44 | 26946041 |
US |
66 | 1 |
Device defective, Drug dose omission by device, Liquid product physical issue, Device leakage, |
||||
ABALOPARATIDE, |
||||
| 45 | 26946151 |
US |
80 | 2 |
Drug dose omission by device, Wrong technique in product usage process, Device mechanical issue, |
||||
ABALOPARATIDE, CELECOXIB, GABAPENTIN, |
||||
| 46 | 26946271 |
US |
57 | 2 |
Visual impairment, Drug delivery system issue, Drug dose omission by device, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 47 | 26946316 |
CO |
2 | |
Drug dose omission by device, Device power source issue, |
||||
SOMATROPIN, |
||||
| 48 | 26946347 |
US |
2 | |
Visual impairment, Injection site pain, Headache, Insomnia, Fatigue, Bone pain, Pain, Drug hypersensitivity, Product dose omission in error, Device defective, Device physical property issue, Drug dose omission by device, Needle issue, Product communication issue, Injury associated with device, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 49 | 26946369 |
US |
84 | 2 |
Injection site pain, Injection site reaction, Fatigue, Device malfunction, Drug dose omission by device, Product dose omission in error, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 50 | 26946514 |
US |
2 | |
Device mechanical issue, Device delivery system issue, Device failure, Drug dose omission by device, |
||||
ABALOPARATIDE, |
||||
| 51 | 26946627 |
US |
84 | 1 |
Drug dose omission by device, Product supply issue, Device malfunction, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 52 | 26946762 |
US |
61 | 2 |
Device mechanical issue, Device failure, Drug dose omission by device, |
||||
ABALOPARATIDE, |
||||
| 53 | 26946804 |
US |
53 | 2 |
Device delivery system issue, Drug dose omission by device, Device issue, |
||||
ABALOPARATIDE, |
||||
| 54 | 26946866 |
US |
84 | 2 |
Drug dose omission by device, Device delivery system issue, Needle issue, |
||||
ABALOPARATIDE, |
||||
| 55 | 26946914 |
US |
80 | 2 |
Arthralgia, Dizziness, Pain, Drug dose omission by device, Device mechanical issue, Wrong technique in product usage process, Product communication issue, |
||||
ABALOPARATIDE, |
||||
| 56 | 26947013 |
US |
64 | 2 |
Device defective, Drug dose omission by device, |
||||
ABALOPARATIDE, |
||||
| 57 | 26947106 |
US |
45 | 2 |
Device malfunction, Device leakage, Drug dose omission by device, |
||||
| 58 | 26947126 |
US |
2 | |
Product adhesion issue, Drug dose omission by device, |
||||
ESTRADIOL, ESTRADIOL, ESTRADIOL, ESTRADIOL, |
||||
| 59 | 26947171 |
US |
54 | 2 |
Drug dose omission by device, Product dose omission issue, Product use issue, Device mechanical issue, |
||||
ABALOPARATIDE, |
||||
| 60 | 26947188 |
US |
2 | |
Device defective, Drug dose omission by device, Wrong technique in device usage process, |
||||
ABALOPARATIDE, |
||||
| 61 | 26947218 |
US |
47 | 2 |
Device defective, Product administered at inappropriate site, Product dose omission issue, Drug dose omission by device, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 62 | 26947363 |
US |
85 | 2 |
Device operational issue, Device failure, Device breakage, Drug dose omission by device, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 63 | 26947382 |
US |
62 | 2 |
Flushing, Night sweats, Dizziness, Heart rate increased, Injection site haemorrhage, Product dose omission in error, Drug dose omission by device, Device issue, |
||||
ABALOPARATIDE, |
||||
| 64 | 26947467 |
US |
64 | 2 |
Device delivery system issue, Product contamination with body fluid, Drug dose omission by device, |
||||
ABALOPARATIDE, |
||||
| 65 | 26947489 |
US |
2 | |
Urticaria, Allergy to plants, Device malfunction, Drug dose omission by device, Device difficult to use, |
||||
ABALOPARATIDE, |
||||
| 66 | 26947494 |
US |
59 | 2 |
Injection site bruising, Drug delivery system issue, Device use issue, Device issue, Wrong technique in product usage process, Drug dose omission by device, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 67 | 26947519 |
US |
79 | 2 |
Dry mouth, Drug dose omission by device, Liquid product physical issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 68 | 26947532 |
US |
36 | 2 |
Skin irritation, Injection site pain, Device mechanical issue, Product use issue, Drug dose omission by device, Incorrect dose administered by device, Product use issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 69 | 26947600 |
US |
46 | 2 |
Device delivery system issue, Drug dose omission by device, |
||||
ABALOPARATIDE, |
||||
| 70 | 26947661 |
US |
83 | 2 |
Drug dose omission by device, Device mechanical issue, |
||||
ABALOPARATIDE, |
||||
| 71 | 26947724 |
US |
54 | 1 |
Device defective, Drug dose omission by device, |
||||
ABALOPARATIDE, |
||||
| 72 | 26947822 |
US |
59 | 2 |
Skin irritation, Herpes zoster, Device malfunction, Product use issue, Drug dose omission by device, Product administered at inappropriate site, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 73 | 26947877 |
US |
73 | 2 |
Needle issue, Device physical property issue, Drug dose omission by device, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, |
||||
| 74 | 26947884 |
US |
2 | |
Drug dose omission by device, Device mechanical issue, |
||||
ABALOPARATIDE, MINOXIDIL, MINOXIDIL FOAM 5% (WOMENS), BIMATOPROST, MELATONIN, VITAMIN C, BIOTIN, IRON, ERGOCALCIFEROL, MAGNESIUM, |
||||
| 75 | 26947908 |
US |
2 | |
Insurance issue, Device operational issue, Product outer packaging issue, Drug dose omission by device, |
||||
ABALOPARATIDE, |
||||
| 76 | 26947913 |
US |
66 | 1 |
Device delivery system issue, Drug dose omission by device, |
||||
ABALOPARATIDE, |
||||
| 77 | 26947933 |
US |
86 | 2 |
Device mechanical issue, Drug dose omission by device, Incorrect dose administered, |
||||
ABALOPARATIDE, |
||||
| 78 | 26947988 |
US |
71 | 2 |
Influenza, Malaise, Device mechanical issue, Device issue, Drug dose omission by device, |
||||
ABALOPARATIDE, |
||||
| 79 | 26948212 |
US |
75 | 2 |
Injection site bruising, Product communication issue, Device difficult to use, Wrong technique in product usage process, Drug dose omission by device, Incorrect product administration duration, |
||||
EVOLOCUMAB, EVOLOCUMAB, TIRZEPATIDE, |
||||
| 80 | 26948262 |
US |
75 | 1 |
Inappropriate schedule of product administration, Wrong technique in device usage process, Drug dose omission by device, Product dose omission in error, Device use issue, Device issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 81 | 26934384 |
US |
2 | |
Therapy interrupted, Cyst, Pain in extremity, Intercepted product storage error, Device difficult to use, Drug dose omission by device, Arthralgia, |
||||
ETANERCEPT, ETANERCEPT, |
||||
| 82 | 26934671 |
US |
76 | 2 |
Injection site erythema, Injection site inflammation, Drug dose omission by device, Device difficult to use, |
||||
EVOLOCUMAB, |
||||
| 83 | 26934732 |
US |
63 | 2 |
Accidental exposure to product, Drug dose omission by device, Exposure via skin contact, |
||||
ETANERCEPT, ETANERCEPT, |
||||
| 84 | 26934752 |
US |
80 | 2 |
Drug dose omission by device, Wrong technique in product usage process, Product storage error, Memory impairment, |
||||
ETANERCEPT, |
||||
| 85 | 26934955 |
US |
80 | 2 |
Stent placement, Device difficult to use, Accidental exposure to product, Drug dose omission by device, Brain fog, |
||||
EVOLOCUMAB, EVOLOCUMAB, ROSUVASTATIN, |
||||
| 86 | 26935230 |
US |
1 | |
Drug dose omission by device, Device defective, Device leakage, Device failure, No adverse event, |
||||
LIRAGLUTIDE, |
||||
| 87 | 26935303 |
US |
80 | 2 |
Injection site pain, Injection site erythema, Incorrect route of product administration, Drug dose omission by device, |
||||
GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, |
||||
| 88 | 26935770 |
US |
75 | 2 |
Disability, Accidental exposure to product, Exposure via skin contact, Product administration error, Product communication issue, Wrong technique in product usage process, Drug dose omission by device, |
||||
DENOSUMAB, |
||||
| 89 | 26936265 |
US |
73 | |
Drug dose omission by device, Recalled product administered, Device leakage, No adverse event, |
||||
PREDNISOLONE ACETATE, LISINOPRIL, |
||||
| 90 | 26936526 |
EU |
2 | |
Device leakage, Drug dose omission by device, |
||||
| 91 | 26936672 |
US |
2 | |
Malaise, Migraine, Drug dose omission by device, |
||||
GALCANEZUMAB-GNLM, |
||||
| 92 | 26936798 |
US |
15 | 2 |
Device information output issue, Drug dose omission by device, |
||||
SOMATROPIN, |
||||
| 93 | 26936820 |
US |
4 | 1 |
Drug dose omission by device, Device information output issue, Device power source issue, |
||||
SOMATROPIN, |
||||
| 94 | 26937055 |
US |
65 | 2 |
Drug dose omission by device, Device difficult to use, Contusion, Macule, |
||||
ERENUMAB-AOOE, |
||||
| 95 | 26937641 |
US |
||
Drug dose omission by device, Device deployment issue, Device delivery system issue, |
||||
MARSTACIMAB-HNCQ, |
||||
| 96 | 26938049 |
US |
64 | 2 |
Drug dose omission by device, Device difficult to use, Cough, |
||||
EVOLOCUMAB, |
||||
| 97 | 26938202 |
|||
Device issue, Drug dose omission by device, Device delivery system issue, |
||||
DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), |
||||
| 98 | 26938759 |
US |
||
Pseudomonas infection, Sputum discoloured, Increased viscosity of upper respiratory secretion, Cough, Feeling abnormal, Product preparation issue, Drug dose omission by device, Device difficult to use, Device defective, |
||||
| 99 | 26938913 |
US |
70 | 2 |
Dizziness, Fatigue, Device defective, Drug dose omission by device, Device issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, ZOLPIDEM TARTRATE, CYCLOBENZAPRINE, ATORVASTATIN CALCIUM, NALOXONE HYDROCHLORIDE NASAL, NALOXONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, PRAMIPEXOLE, OMEPRAZOLE MAGNESIUM, MONTELUKAST SODIUM, CETIRIZINE HYDROCHLORIDE, |
||||
| 100 | 26938940 |
US |
80 | 1 |
Device defective, Drug dose omission by device, Incorrect dose administered by device, |
||||
ABALOPARATIDE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30